Decision Diagnostics Chairman and Director Robert Jagunich Retires from DECN Board of Directors

Decision Diagnostics Corp.

Companies Mentioned:

Primary Exchange: OTC PINK
Under the Symbol: DECN

Decision Diagnostics Chairman and Director Robert Jagunich Retires from DECN Board of Directors

Wednesday, May 31, 2017 7:00 AM

LOS ANGELES, CA / ACCESSWIRE / May 31, 2017 / Decision Diagnostics Corp. (OTC PINK: DECN), the manufacturer, quality plan administrator, and the exclusive worldwide sales, service, and regulatory processes agent for the GenUltimate!™ glucose test strips, designed to work with the market leading Johnson & Johnson's ("J&J") LifeScan OneTouch Ultra family of glucose testing meters, and the pre-market ready GenSure!™ and GenChoice!™ test strips, and the in-development meter and test strip system GenPrecis! for the U.S., EU and/or developing world markets, today announces the retirement of its long time Chairman, Robert Jagunich.

Robert Jagunich commented, "It is with regret that I am taking my leave of DECN. Having just reached my 70th birthday, I have decided to retire and move my life in a different direction. The company is in capable hands and I am confident that the future will reward all who have labored and invested in its success."

Mr. Jagunich has loyally and capably served the company and its shareholders since January 2003. His contributions have been extensive and selfless. He energetically tackled every requested task and met every challenge. His presence, counsel, and enthusiasm will be missed.

Keith Berman, Principal Executive and Director of Decision Diagnostics, commented, "Bob Jagunich and I have known and worked together for 39 years. I have relied on his intelligence, business acumen and common sense during that entire time. He is a close friend and his contributions will leave a void within our Board. We will identify and elect a new director, but quite frankly, Bob Jagunich cannot be replaced."

The company intends to shortly begin evaluating candidates for the now vacant seat on the Board of Directors.

Forward-Looking Statements:

This release contains the Company's forward-looking statements which are based on management's current expectations and assumptions as of May 22, 2017, regarding the Company's business and performance, its prospects, current factors, the economy, and other future conditions and forecasts of future events, circumstances, and results.


Decision Diagnostics Corp.
Keith Berman
(805) 446-2973
[email protected]

SOURCE: Decision Diagnostics Corp.

Subscribe to alerts from Investor Network